1801.HK in “GLP-1 Eats Everything”
Innovent Biologics, Inc.
Innovent commercializes mazdutide, an approved GLP-1/glucagon dual agonist for chronic weight management in China.
1801.HK impact map — “GLP-1 Eats Everything”
How this story travels from the headline to 1801.HK’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.
Loading 1801.HK impact map…
Price history, marked with story events
Oct 20, 2025 – Oct 19, 2026 · 247 sessions
Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions
Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…
Full story
GLP-1 Eats Everything
Appetite suppression as a macro variable.
BULL side — Innovent commercializes mazdutide, an approved GLP-1/glucagon dual agonist for chronic weight management in China.
Read the full GLP-1 Eats Everything storyBull side
3 stories- America Imports the World's Drug Prices
1801.HK in “America Imports the World's Drug Prices”
StableExposure: not rated yetUS reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Innovent's portfolio of lower-cost biosimilars in oncology and immunology can support payer demands for credible alternatives to expensive biologic brands.
- Viewing
1801.HK in “GLP-1 Eats Everything”
FadingExposure: not rated yetAppetite suppression as a macro variable.
Innovent commercializes mazdutide, an approved GLP-1/glucagon dual agonist for chronic weight management in China.
- China Becomes Pharma's Global R&D Engine
1801.HK in “China Becomes Pharma's Global R&D Engine”
FadingExposure: not rated yetWestern drugmakers are licensing clinically validated Chinese molecules rather than relying solely on expensive in-house discovery.
Its broad oncology and metabolic pipeline offers multiple opportunities for overseas licensing and commercialization.
Bear side
0 storiesNo bear-side stories for 1801.HK yet.